The government shutdown in December and January has caused a tremendous backlog of quarterly and year-end filings for review at the SEC. Accordingly, our updated RegA+ Offering Price has not been reviewed.
We will once again open the current Offering for sales of shares at the price of $6.90 per share. This equates to a market capitalization of approximately $33.7 million dollars.
Shares can be purchased beginning at Noon EST on February 13 until Noon EST February 18, 2019. If we get clearance during this period, we will close to new investments at that time.
To start the investment process: https://www.manhattanstreetcapital.com/insitu-biologics-0
Feel free to reach out to me directly with any questions.